Ipamorelin

Ipamorelin is a synthetic pentapeptide designed for research applications. It selectively stimulates growth hormone (GH) secretion while minimizing the release of other hormones, such as prolactin and cortisol, making it a valuable tool in studies investigating growth hormone regulation and potential therapeutic mechanisms.

Research Context

Ipamorelin is a synthetic analog of the naturally occurring peptide GHRP-2 (Growth Hormone-Releasing Peptide-2). Originally developed for preclinical and experimental studies, it has been utilized to explore GH secretion dynamics, muscle protein synthesis, and metabolic pathways. Its selective activity on GH release makes it a preferred choice in research settings where precise hormonal modulation is required.

Research Overview

Ipamorelin acts through a specific receptor on pituitary cells, triggering a cascade that promotes the secretion of growth hormone (GH). Unlike traditional GH-releasing peptides, ipamorelin does not elicit prolactin or cortisol release, reducing confounding effects in experimental designs. This specificity has made it a valuable tool in studies examining GH-dependent processes, such as muscle regeneration, bone growth, and tissue repair.

Key Research Focus Areas

• Growth Hormone (GH) Secretion Studies
• Muscle Protein Synthesis and Regeneration Research
• Metabolic Pathway Investigation
• Selective Hormonal Modulation in Experimental Models
• Potential Mechanistic Insights in Anti-Aging and Tissue Repair

Important Safety and Compliance Note

Ipamorelin is intended solely for research purposes and is not approved for therapeutic, diagnostic, or cosmetic use in humans or animals. All research involving ipamorelin must comply with local regulations, ethical guidelines, and institutional protocols. Handling and storage should follow standard laboratory practices to ensure safety and accuracy. For research use only. Not for human or animal consumption.